Table 2 In vitro screening of the bacterial isolates for IAA production, ARA, and ACC deaminase activity

CoY3

11.61 ± 0.49^l

36.35 ± 0.10^nm

10.04 ± 1.65^h

–

CoY7

15.70 ± 0.34^h

44.82 ± 0.61^k

16.65 ± 1.25^fg

34.72 ± 5.33^d

CoY8

11.42 ± 0.49^l

49.26 ± 0.69^j

17.65 ± 0.27^ef

–

CoA1

17.12 ± 0.33^fg

42.14 ± 0.21^l

5.53 ± 0.56ⁱ

–

CoA10

12.56 ± 0.25^kl

51.84 ± 0.10^ij

16.74 ± 0.18^fg

–

AY6

14.10 ± 0.34^ij

49.20 ± 0.34^j

21.38 ± 2.42^cd

19.60 ± 0.89^e

AY7

26.25 ± 0.51^d

53.84 ± 0.27ⁱ

21.59 ± 3.65^cd

39.80 ± 1.10^c

AY8

17.27 ± 0.20^fg

316.84 ± 2.5^b

25.89 ± 2.08^ab

–

AN8

19.13 ± 0.51^e

290.57 ± 2.62^c

24.73 ± 0.61^ab

17.42 ± 0.55^e

AN11

39.92 ± 2.95^b

104.62 ± 0.51^h

26.59 ± 2.05^a

–

AN12

17.37 ± 0.61^f

112.27 ± 1.28^g

19.70 ± 0.67^de

–

BN5

15.41 ± 0.11^h

271.06 ± 2.45^d

23.62 ± 1.15^bc

–

CY5

44.88 ± 0.19^a

35.01 ± 0.30^mn

23.87 ± 2.55^bc

75.63 ± 3.35^a

CY9

14.03 ± 0.30^ij

49.33 ± 0.63^j

25.87 ± 1.72^ab

–

CY10

14.98 ± 0.26^hi

33.84 ± 0.11ⁿ

2.40 ± 0.24^j

32.92 ± 4.23^d

CY11

43.77 ± 0.23^a

175.73 ± 0.91^e

16.12 ± 0.94^fg

41.57 ± 3.91^c

CA1

16.14 ± 0.10^gh

130.96 ± 1.81^f

15.94 ± 2.11^fg

49.61 ± 1.15^b

CA6

13.28 ± 0.25^jk

37.10 ± 0.41^m

14.23 ± 1.07^g

–

CA8

17.42 ± 0.18^f

29.65 ± 0.61^o

15.08 ± 1.17^fg

16.47 ± 0.42^e

CN13

28.28 ± 0.47^c

36.12 ± 1.93^mn

16.87 ± 0.92^fg

21.05 ± 1.04^e

CN14

13.90 ± 0.19^ij

37.56 ± 0.30^m

16.92 ± 1.71^fg

–

N1

18.64 ± 0.15^e

339.07 ± 5.56^a

17.69 ± 0.76^ef

–

SEM

0.39

0.89

0.86

1.62

CD (P = 0.05)

1.12

2.55

2.44

4.87

CV (%)

3.40

1.50

8.30

7.60